Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
STLN
Showing 8 of 14 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in Starling Oncology, Inc.
No. Balyasny Asset Management exited its STLN (Starling Oncology) position in Q2 2026. Its Q1 2026 13F listed 1,826,370 shares worth $5.6M. Balyasny Asset Management first reported STLN in Q1 2022 and held it in 12 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$564,086
Total Shares Change
-1.7M
Quarter-by-Quarter History